Income Taxes (Tables)

12 Months Ended

Dec. 31, 2024

Income Taxes [Abstract]

Schedule of Loss Before Provision (benefit) for Income Taxes

Loss before provision (benefit) for income taxes for the years ended December 31, 2024 and 2023 consisted of the following:

	For the Year Ended December 31,
	2024			2023
United States	$	(7,372,032	)	$	(3,006,861	)
Foreign		(583,381	)		(806,689	)
Total Loss before Income Taxes	$	(7,955,413	)	$	(3,813,550	)

Schedule of Components of the Provision (benefit) for Income Taxes

The components of the provision (benefit) for income taxes consisted of the following:

	For the Year Ended December 31,
	2024		2023
Current:
Federal	$	-	$	-
State		250		250
Foreign		-		-
Total current provision (benefit)		250		250
Deferred:
Federal		-		-
State		-		-
Foreign		-		-
Total deferred provision (benefit)		-		-
Total Benefit	$	250	$	250

Schedule of Income Taxes Computed at the U.S. Statutory Income Tax

The reconciliation between income taxes computed at the U.S. statutory income tax rate to the Company’s provision (benefit) for income taxes for the years ended December 31, 2024 and 2023 are as follows:

	For the Year Ended December 31,
	2024					2023
Benefit for income taxes at 21% rate	$	(1,670,637	)	21.0	%	$	(800,846	)	21.0	%
State income taxes, net of federal benefit		(587,971	)	7.4			(364,618	)	9.6
Tax credits		(437,296	)	5.5			-		-
Impact of non-U.S. earnings		(22,103	)	0.3			(33,994	)	0.9
Permanent differences		(347,008	)	4.4			280,654		(7.4	)
Change in fair value of promissory note		-		-			(1,129,646	)	29.6
Non-deductible interest expense		-		-			304,962		(8.0	)
Other reconciling items, net		30,411		(0.4	)		2,042,657		(53.6	)
Change in valuation allowance		3,034,854		(38.1	)		(298,919	)	7.8
Benefit for Income Taxes	$	250		0.0	%	$	250		(0.1	)%

Schedule of Deferred Tax Assets (liabilities)

Significant components of the Company’s deferred tax assets (liabilities) as of December 31, 2024 and 2023 are as follows:

	As of December 31,
	2024			2023
Deferred tax assets:
Net operating loss carry-forward	$	4,191,575		$	3,498,043
Tax credits		437,296			-
Non-deductible reserves		44,733			1,058
Capitalized R&D costs		1,268,685			189,892
Lease liability		-			3,756
Share-based compensation		41,830			94,034
Gross deferred tax assets		5,984,119			3,786,783
Less valuation allowance		(5,915,350	)		(3,088,051	)
Total deferred tax assets, net of valuation allowance		68,769			698,732
Deferred tax liabilities:
Fixed asset depreciation		(2,783	)		-
Right of use asset		-			(3,719	)
Prepaid expenses		(65,986	)		(695,013	)
Total deferred tax liabilities		(68,769	)		(698,732	)
Net deferred tax liabilities	$	-		$	-